Reach Us +447482877761
Myc-p53 Interactions Illustrate A Paradigm For Coupled Oncogene-tumor Suppressor Dynamic Control Of Cancer Development | 9360
ISSN: 0974-7230

Journal of Computer Science & Systems Biology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

16th World Congress on Structural Biology

Amsterdam, Netherlands
Share This Page

Myc-p53 interactions illustrate a paradigm for coupled oncogene-tumor suppressor dynamic control of cancer development

International Conference on Integrative Biology Summit

Baltazar D. Aguda

Accepted Abstracts: J Comput Sci Syst Biol

DOI: 10.4172/0974-7230.S1.004

Myc and p53 are both transcription factors, each affecting the expression of thousands of genes. Two recent census of human cancer genes list Myc and p53 in the top groups of frequently amplified and mutated genes, respectively. Myc is an oncogene that promotes cell proliferation and inhibits cell differentiation, whereas p53 is a tumor suppressor gene that inhibits proliferation and promotes differentiation. We have summarized the published literature on pathways of interactions between Myc and p53; and we show that most of the pathways form negative feedback loops (i.e., Myc upregulates p53 activity while p53 downregulates Myc). In many cancers, however, positive feedback interactions (i.e., mutual antagonism) between Myc and p53 may predominate. I will discuss how one can quantify the strengths of the positive and negative feedback loops, thereby allowing us to make predictions on how to control Myc activity. I will also give other examples of oncogene-tumor suppressor gene interactions and argue for the proposal that cancer therapy should be designed in the context of controlling the network of interactions between oncogenes and their associated tumor suppressor genes.
Aguda obtained his Ph.D. in Chemistry (Chemical Physics Program) and was a faculty member of a few Canadian and US universities before he re- focused his research program on cancer systems biology and moved to NCI in 2010. Some of his substantial contributions include the development of predictive network and kinetic models of mammalian cell cycle checkpoints such as the Restriction Point and the G2 DNA Damage Checkpoint Pathway. He and Professor Avner Friedman wrote the graduate-level book Models of Cellular Regulation published in 2008 by Oxford University Press. At the NCI, He works in the field of network pharmacology.